5 Best Small-Cap Stocks to Buy Today
| Company (Ticker) | 12 Week Price Change | Forward PE | Price | Proj EPS Growth (1 Year) | Projected Sales Growth (1Y) |
|---|---|---|---|---|---|
| CION Investment Corporation (CION) | 5.69% | 6.66 | $9.62 | -19.89% | -13.23% |
| Array Technologies (ARRY) | 0.97% | 9.15 | $9.00 | 44.62% | 18.38% |
| LiveRamp (RAMP) | 2.02% | 12.51 | $27.90 | 30.59% | 8.69% |
| Pursuit Attractions and Hospitality, Inc. (PRSU) | -4.77% | 26.62 | $34.18 | -1.16% | 7.39% |
| CorMedix (CRMD) | -25.50% | 2.61 | $7.63 | 0.46% | 47.88% |
*Updated on January 10, 2026.
CION Investment Corporation (CION)
$9.62 USD -0.04 (-0.41%)
3-Year Stock Price Performance
Premium Research for CION
- Zacks Rank
- Strong Buy 1
- Style Scores
A Value A Growth C Momentum A VGM
- Market Cap:$503.16 M
- Projected EPS Growth:1.12%
- Last Quarter EPS Growth:131.25%
- Last EPS Surprise:111.43%
- Next EPS Report date:March 12, 2026
Our Take:
CION Investment is a business development company (BDC) focused on first-lien senior secured lending to middle-market borrowers. It carries a $503.2 million market cap. A Zacks Rank #1 (Strong Buy) reflects positive estimate revisions. Style Scores of A for Value and Growth and C for Momentum underscore attractive yield and improving fundamentals despite average momentum. It suits investors seeking durable cash generation.
In the last reported quarter, CION posted 74 cents of NII per share, up 85% year over year, and maintained a portfolio of 80% in first-lien loans, which signals disciplined risk management and healthy yields. Management intends to pay base distributions monthly, starting from January 2026.
On the Price, Consensus & EPS Surprise chart, shares are based on the 2026–27 EPS lines, suggesting stabilizing book value and estimate momentum. That backdrop, plus regular distributions, supports a balanced total-return profile for this small-cap BDC.
Array Technologies (ARRY)
$9.00 USD +0.15 (1.69%)
3-Year Stock Price Performance
Premium Research for ARRY
- Zacks Rank
Strong Buy 1
- Style Scores
B Value C Growth A Momentum A VGM
- Market Cap:$1.35 B
- Projected EPS Growth:11.67%
- Last Quarter EPS Growth:17.39%
- Last EPS Surprise:42.86%
- Next EPS Report date:Feb. 26, 2026
Our Take:
Array makes utility-scale solar trackers used by developers worldwide and has a market cap below $1.4 billion. A Zacks Rank #1 with Style Scores of B for Value, C for Growth and A for Momentum points to fresh estimate support and improving price action, offsetting mixed growth as the cycle normalizes.
In the last reported quarter, it witnessed significant revenue and volume growth and robust bookings backed by expanding partnerships. The APA acquisition last August is bringing meaningful commercial synergies. It has 267 active patents and 177 pending. Its focus on disciplined margin priorities is bearing fruit.
On the chart, the stock’s recent base forms alongside a rising out-year consensus line, implying that estimate revisions are starting to lead price. Its sizeable order book, with more than 95% domestic projects, makes ARRY a contrarian small-cap solar pick into a steadier demand environment.
LiveRamp (RAMP)
$27.90 USD +0.13 (0.47%)
3-Year Stock Price Performance
Premium Research for RAMP
- Zacks Rank
- Strong Buy 1
- Style Scores
C Value A Growth B Momentum A VGM
- Market Cap:$1.77 B
- Projected EPS Growth:30.59%
- Last Quarter EPS Growth:471.43%
- Last EPS Surprise:14.58%
- Next EPS Report date:Feb. 4, 2026
Our Take:
LiveRamp provides a data-collaboration platform used by brands and publishers. Its market cap is about $1.8 billion. A Zacks Rank #1 and a Growth Score of A reflect sustained double-digit revenue expansion and improving profitability, while a Momentum Score of B and Value Score of C are more mixed, appropriate for a software model reinvesting in platform scale.
In the last reported quarter, revenue increased 8% with stable adjusted gross margin and cash generation. Customer metrics - $1M+ customers at 132 and ARR up 7% year over year, support durable subscription growth as clean rooms and retail media partnerships broaden the network. Platform net retention came in at 105%.
The chart shows shares consolidating while 2026–27 consensus has edged higher, consistent with estimate momentum. That setup, coupled with buybacks and rising platform stickiness, frames an appealing small-cap compounder in data connectivity.
Pursuit Attractions and Hospitality, Inc. (PRSU)
$34.18 USD +0.24 (0.71%)
3-Year Stock Price Performance
Premium Research for PRSU
- Zacks Rank
Strong Buy 1
- Style Scores
B Value C Growth C Momentum B VGM
- Market Cap:$959.93 M
- Projected EPS Growth:960.00%
- Last Quarter EPS Growth:636.11%
- Last EPS Surprise:3.52%
- Next EPS Report date:March 10, 2026
Our Take:
Pursuit operates experiential attractions and destination lodges across North America and Iceland, with a market cap of nearly $960 million. A Zacks Rank #1 and Style Scores of B for Value and C for Growth and Momentum point to constructive estimate trends and balanced factor exposure as the pure-play entity faces strong demand across its Canadian operations.
The last reported quarter delivered record results as it raised full-year guidance, driven by broad-based demand, margin expansion from operating leverage, and Jasper’s recovery. That momentum supports forward estimates into the peak travel seasons and validates the focused strategy.
On the chart, estimates for out-years have stabilized and begun to lift as shares recover from earlier volatility, indicating improving visibility. Seasonal strength and asset upgrades are key drivers to watch as the company continues its “Refresh, Build, Buy” investment strategy across high-traffic destinations.
CorMedix (CRMD)
$7.63 USD +0.12 (1.60%)
3-Year Stock Price Performance
Premium Research for CRMD
- Zacks Rank
- Strong Buy 1
- Style Scores
A Value B Growth A Momentum A VGM
- Market Cap:$591.71 M
- Projected EPS Growth:1,056.67%
- Last Quarter EPS Growth:103.57%
- Last EPS Surprise:18.75%
- Next EPS Report date:March 24, 2026
Our Take:
CorMedix is a commercial-stage biotech marketing DefenCath for infection prevention in hemodialysis. Its market cap is roughly $592 million. A Zacks Rank #1 with Style Scores of A for Momentum and Value and B for Growth captures positive revisions and accelerating launch trends after FDA approval.
Its fourth quarter 2025 preliminary results revealed robust utilization and patient growth. Higher utilization is likely to offset some of the price erosion expected in 2026. The Melinta acquisition continues to provide operational synergies. It closed 2025 with a strong cash position, which is expected to further bolster in 2026.
The chart shows price strength following rising 2026–27 consensus lines, reflecting early launch momentum. Execution on payer dynamics and hospital penetration remains the key swing factor, but the inflection is clear. The Phase 3 study of taurolidine/heparin catheter lock solution in TPN patients continues to enroll, with completion targeted for early 2027.
Methodology
The Zacks Rank is a proprietary stock-rating model that uses trends in earnings estimate revisions and earnings-per-share (EPS) surprises to classify stocks into five groups: #1 (Strong Buy), #2 (Buy), #3 (Hold), #4 (Sell) and #5 (Strong Sell). The Zacks Rank is calculated through four primary factors related to earnings estimates: analysts' consensus on earnings estimate revisions, the magnitude of revision change, the upside potential and estimate surprise (or the degree in which earnings per share deviated from the previous quarter).
Zacks builds the data from 3,000 analysts at over 150 different brokerage firms. The average yearly gain for Zacks Rank #1 (Strong Buy) stocks is +23.62% per year from January, 1988, through June 2, 2025.
For this list, only companies trading 100,000 shares or more daily and in the top 50% of industries were considered. All stocks had a Zacks Rank #1 rank at the time of selection. All information is current as of market open, Jan. 9, 2026.
Guide to Best Small-Cap Stocks
What Are Small-Cap Stocks?
“Small-cap” refers to publicly traded companies whose market capitalisation falls below a certain threshold. The exact cutoff varies by region or index provider, but commonly in the U.S. small-caps are defined as roughly $300 million to $2 billion in market cap.
Why Invest in Small-Cap Stocks
- Growth potential: Because these companies are smaller, they have more runway to grow revenues, profits and market share.
- Diversification: They often behave differently than large-cap stocks, so including them can enhance portfolio diversification.
- Value opportunity: Many small-caps are currently trading at valuations below historical norms or relative to large caps — offering potential mispricing opportunities.
Small-Cap vs Mid-Cap vs Large-Cap Stocks
Small Cap:
- Market capitalization of between $300 million to $2 billion (but designation can vary among indices).
- Higher growth potential, but higher risk and less liquidity.
- More volatile and more sensitive to economic and interest rate shifts.
Medium (Mid) Cap:
- Market capitalization generally from $2 billion to $10 billion.
- Balanced between growth and stability.
- Fewer extremes than small caps, but possibly less upside.
Large Cap:
- Market cap is usually over $10 billion.
- Established companies, lower growth but more stability.
Benefits of Investing in Small-Cap Stocks
- Potential for outsized returns if a small company scales successfully.
- Greater market inefficiencies — less analyst coverage means more opportunity for undervalued gems.
- Cyclical upside — when conditions improve (such as lower rates or economic recovery) small caps often lead the trend.
Risks and Challenges of Small-Cap Stocks
- Higher volatility — More price swings, less predictable earnings.
- Sensitivity to economic and interest rate cycles — Small cap companies often carry more floating rate debt, shorter maturities, and weaker financials. Small cap stocks are generally “more vulnerable” in elevated-interest rate environments.
- Less liquidity and coverage — Small cap stocks may be harder to trade, with fewer analysts covering them and less public information
- Greater capital risk — Many small-cap firms are still unprofitable; their future may be less certain.
Small-Cap ETFs vs Small-Cap Stocks
- ETFs: Small-cap exchange traded funds provide instant diversification, lower company-specific risk, simpler to invest.
- Individual stocks: Offer higher potential upside (and higher risk). You can benefit from picking a breakout company, but the odds of mis-steps are higher.
- If you believe in the asset class broadly, a small-cap ETF may be a smarter choice; if you want to hand-pick potential winners and accept higher risk, then individual stocks might appeal.
How to Choose the Best Small-Cap Stocks
Look at factors like:
- Business quality: Profitability (or path to profitability), return on invested capital, competitive advantage (often known as a ‘moat”).
- Financial strength: Manageable debt, good cash flow and reasonable valuation.
- Valuation: Since small caps are currently trading at depressed valuations relative to large caps, finding ones that are both good quality and cheap may give you an edge.
- Sector and cycle fit: Because many small-caps are more cyclical, consider how economic or rate trends might affect them.
- Liquidity and transparency: Ensure the company has sufficient trading volume and good public disclosure.
- Time horizon: Small-cap investing often requires patience — these stocks may take time to execute and get recognised by the market.
How to Invest in Small-Cap Stocks
- Decide your allocation: How much of your portfolio are you willing to place into higher-risk small caps?
- Combined approach: Consider holding a small-cap ETF and a few hand-picked individual names for upside.
- Use dollar-cost averaging to smooth entry over time (given the greater volatility of small cap stocks.)
- Monitor macroeconomic variables: Interest rates, economic growth, inflation, liquidity — these matter for small caps.
- Stay disciplined: Set stop-losses or position limits; avoid over-allocating to speculative names
- Review your time horizon: Small caps typically work better when held for multiple years rather than trading in and out.
Tips for Building a Small-Cap Portfolio
- Diversify across sectors to avoid concentration risk (such as spreading across small-cap healthcare, industrial, consumer stocks and so forth).
- Blend quality and speculative: Have some “core” small-cap holdings with proven businesses plus some high-upside speculative names.
- Watch weighting: Don’t let any one small-cap issue become too big a part of your portfolio.
- Track valuations: Since small-cap valuations can re-rate, be ready to adjust when valuations seem stretched.
- Stay updated on macro shifts: For example, rate cuts can help small-caps more than large caps. Medium term, that dynamic could drive performance.
Frequently Asked Questions About Small-Cap Stocks
How long should I hold small-cap stocks?
Because of their risk and growth nature,a time horizon of 3-5 years or more is generally preferable. Short-term trading can be risky due to volatility and structural shifts.
Are small-cap stocks suitable for beginners?
They can be, but only if the investor understands the risks, is comfortable with volatility and uses appropriate position sizing. Beginners might start with ETFs or limit exposure rather than going heavy into speculative names.
What sectors do the best small-cap stocks usually come from?
Historically: industrials, consumer discretionary, healthcare/biotech, technology. Small caps tend to have more cyclical exposure compared to large caps.
Also note many small-caps fly under the radar.
Can small-cap stocks be dividend-paying?
Yes — though less commonly than large-caps. Many small-cap companies reinvest profits into growth rather than returning dividends. But some mature small-caps may pay dividends.
What is the historical performance of small-cap stocks?
- Historically small-caps offered a “small-cap premium” over large-caps due to greater growth potential.
- However, more recently this premium has eroded — for example, J.P. Morgan reports that the small-cap growth engine has diminished in recent years.
- Still, some data suggests that when macro conditions shift (such as interest rate cuts and economic recovery), small caps tend to outperform large caps.
